Related Experiment Video
Updated: Nov 9, 2025
10:04
Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
Published on: March 13, 2018
12.3K
Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting
Mark Steven Miller1, Peter J Allen2, Powel H Brown3
1Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland, USA.
Journal of Cancer Prevention
|April 12, 2021
Summary
This meeting advanced cancer prevention research by fostering collaboration and highlighting new trends in chemoprevention and immunoprevention. It also informed researchers about National Cancer Institute resources for agent development and clinical trials.
Area of Science:
- Oncology
- Preventive Medicine
- Translational Research
Background:
- The National Cancer Institute (NCI) and NIH Office of Disease Prevention convened a meeting on cancer prevention agent development.
- Key stakeholders in cancer prevention research were brought together.
Purpose of the Study:
- To foster idea exchange and collaboration among basic and clinical cancer prevention researchers.
- To highlight emerging trends in immunoprevention and chemoprevention.
- To inform the research community about NCI resources for agent development and clinical trials.
Main Methods:
- The meeting featured two plenary talks and five sessions.
- Discussions spanned preclinical studies to ongoing clinical trials for cancer prevention agents.
- Informational sessions detailed NCI contract resources and grant opportunities.
Main Results:
- Facilitated exchange of ideas and stimulated new collaborative interactions.
- Showcased new trends in immunoprevention and chemoprevention.
- Provided information on NCI resources for preclinical and clinical development.
Conclusions:
- The meeting successfully promoted collaboration and knowledge sharing in cancer prevention.
- Enhanced awareness of resources available for advancing cancer prevention agent development.
- Strengthened the pipeline for translating cancer prevention strategies into clinical practice.
Related Concept Videos
02:59Cancer Prevention
7.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.2K
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
02:18Cancer
51.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.6K
01:30Cancer Vaccines
605
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
605
03:03mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K